Verition Fund Management LLC Dexcom Inc Call Options Transaction History

Verition Fund Management LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $2.83 Million - $3.61 Million	25,700 Added 450.88%	31,400 $3.56 Million
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $651,054 - $798,570	5,700 New	5,700 $790,000
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $1.03 Million - $1.22 Million	9,900 Added 88.39%	21,100 $2.45 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $951,776 - $1.37 Million	11,200 New	11,200 $1.27 Million
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $423,360 - $585,900	4,500 Added 112.5%	8,500 $4.35 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $426,840 - $572,720	4,000 New	4,000 $2.19 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.